53 related articles for article (PubMed ID: 35220072)
1. Arginase is involved in cervical lesions progression and severity.
Souid M; Ghedira R; Souissi S; Bouzgarrou N; Gabbouj S; Shini-Hadhri S; Rhim MS; Boukadida A; Toumi D; Faleh R; Bouaouina N; Zakhama A; Hassen E
Immunobiology; 2022 Mar; 227(2):152189. PubMed ID: 35220072
[TBL] [Abstract][Full Text] [Related]
2. Arginase is upregulated in healthy women infected by oncogenic HPV types.
Souid M; Bday J; Souissi S; Ghedira R; Gabbouj S; Shini-Hadhri S; Toumi D; Bergaoui H; Zouari I; Faleh R; Zakhama A; Hassen E
Biomarkers; 2023 Dec; 28(7):628-636. PubMed ID: 37860844
[TBL] [Abstract][Full Text] [Related]
3. Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: Results from a large-scale cross-sectional study.
Wu Z; Qin Y; Yu L; Lin C; Wang H; Cui J; Liu B; Liao Y; Warren D; Zhang X; Chen W
J Med Virol; 2017 Mar; 89(3):535-541. PubMed ID: 27464021
[TBL] [Abstract][Full Text] [Related]
4. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
[TBL] [Abstract][Full Text] [Related]
5. [The Clinical Significance of HPV L1/PD-L1 Tests Combined with Colposcopy for Cervical Precancerous Lesions and Cervical Cancer].
Luo GP; Zeng X; Cao HY; Tang D; Xi MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):516-522. PubMed ID: 34018374
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
7. [Viral load, genomic integration frequency of human papillomavirus 16 in cervical cancer and precancerous lesions].
Li Y; Xiang Y; Zhang RF; Cai YP; Yang Y; Cheng XM; Zhu BL
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(13):906-10. PubMed ID: 21600119
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010-2019.
Lu W; Chen T; Yao Y; Chen P
J Med Virol; 2021 Aug; 93(8):5118-5125. PubMed ID: 33913528
[TBL] [Abstract][Full Text] [Related]
9. Local cervical immunity in women with low-grade squamous intraepithelial lesions and immune responses after abrasion.
Ekalaksananan T; Malat P; Pientong C; Kongyingyoes B; Chumworathayi B; Kleebkaow P
Asian Pac J Cancer Prev; 2014; 15(10):4197-201. PubMed ID: 24935370
[TBL] [Abstract][Full Text] [Related]
10. HPV genotype distribution and anomalous association of HPV33 to cervical neoplastic lesions in San Luis Potosí, Mexico.
DelaRosa-Martínez R; Sánchez-Garza M; López-Revilla R
Infect Agent Cancer; 2016; 11():16. PubMed ID: 27030798
[TBL] [Abstract][Full Text] [Related]
11. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
12. The value of HPV E6/E7 mRNA quantitative analysis in distinguishing high-grade cervical squamous intraepithelial lesions from low-grade cervical squamous intraepithelial lesions.
Liu J; Yang T; Hu Y; Ye C
J Virol Methods; 2021 Mar; 289():114014. PubMed ID: 33188806
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of high-risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage.
Wang M; Hou B; Wang X; Han L; Shi Y; Zhang Y; Zhang L; Liu L; Jin F; Zhang Y
Cancer Med; 2021 Apr; 10(7):2482-2488. PubMed ID: 33682355
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma.
Wu MZ; Li WN; Cha N; Tian LX; Zhang YI; Wu X; Guo KJ; Wu GP
Cell Transplant; 2018 Sep; 27(9):1401-1406. PubMed ID: 30056761
[TBL] [Abstract][Full Text] [Related]
15. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
[TBL] [Abstract][Full Text] [Related]
16. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus types distribution in eastern Sicilian females with cervical lesions. A correlation with colposcopic and histological findings.
Le Donne M; Giuffrè G; Caruso C; Nicotina PA; Alibrandi A; Scalisi R; Simone A; Chiofalo B; Triolo O
Pathol Oncol Res; 2013 Jul; 19(3):481-7. PubMed ID: 23420303
[TBL] [Abstract][Full Text] [Related]
18. E4 expression of human papillomavirus in cervical samples with different cytology categories.
Supchokpul A; Chansaenroj J; Theamboonlers A; Payungporn S; Kamolvarin N; Sampathanukul P; Junyangdikul P; Swangvarees S; Karalak A; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1113-8. PubMed ID: 22299437
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
20. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
